Back

PRIME Education, Inc. (PRIME®)

  • Polymyalgia Rheumatica

An Expert TheraTalk on the Latest Advances in Polymyalgia Rheumatica: From Accurate Diagnosis to Novel Targeted Treatments

Polymyalgia rheumatica (PMR) is an inflammatory condition characterized by intense pain and inflammation in the shoulders, neck, and hips that limits patient mobility and daily living. Due to a lack of specific diagnostic criteria, delays in identification cause under- and overtreatment while contributing to a heavy burden on patients and the healthcare system. Although steroids have been a mainstay of PMR management, long-term use is associated with a risk of complications. Novel insights into PMR pathophysiology have led to the development of targeted treatments with the potential to improve outcomes and minimize steroid exposure.Join prominent PMR experts for this live TheraTalk webinar, featuring video-based patient testimonials on their diagnostic journey and impact on quality of life, a 2D animation illustrating novel treatment targets within PMR pathogenesis, and expert analyses of the latest data for new therapies. You will also have the opportunity to download a Point-of-Care PMR Diagnostic Toolkit and get your most pressing questions about PMR answered by renowned faculty.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
Start Date
December 2, 2026
End Date
December 4, 2026

Target Specialties

No specific specialties targeted.

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 1 credit
  • Commercial Support
  • When
    Dec 2–3, 2026